Madeleine Farman
Madeleine Farman is the editor of PEI Group’s Secondaries Investor title based in London. Prior to joining PEI, she had covered private equity, private capital and advisers associated with the industry for other newsrooms and publications since 2016. Originally from New Zealand, Madeleine began her career in radio in Auckland.
The GP stakes giant is ‘excited’ at the prospect of working with the tail-end specialist to grow it into ‘one of the premier operators in this market’, founding partner and chief executive John Carter tells Secondaries Investor.
Hollyport Capital has chosen to remain independent, accepting the backing of Blue Owl in a move that reflects how the industry's growth is likely to be fuelled.
Blue Owl has acquired a passive stake in the tail-end specialist, which will ‘ultimately represent’ approximately 25% of the economic interests of the firm.
Four of the firm's cornerstone evergreen products are heavily weighted to secondaries investments.
The new vehicle will house over $500m of debt positions held by TCPC, with pricing coming in at 95% of gross fair value as of 31 December 2025.
Carlyle increasingly views AlpInvest as more of corporate finance business than a standalone secondaries unit, chief executive Harvey Schwartz said on the firm's Q2 2026 earnings call.
The Switzerland-headquartered manager will seek to invest in LP-led, GP-led and opportunistic deals with an emphasis on senior lending, Secondaries Investor understands.
The insurer had shopped a portfolio of funds and co-investments with a net asset value of $1.8bn, Secondaries Investor understands.
The Chicago-based firm’s $2.7bn Fund 8, raised as part of a $5bn secondaries programme, seeks a 50/50 split for LP-led and GP-led deployment, with a focus on North America and Europe.
KKR believes it can build a ‘world-class’ business targeting the sub-segment, CFO Robert Lewin said on the firm’s Q2 2026 earnings call.